Luke Tolar

Role: Alzheon, Inc Preserving Future Memories at Alzheon, Inc
Location: Boston, MA, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

Experience

Alzheon, Inc Preserving Future Memories
Alzheon, Inc
Present

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@alzheon.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Alzheon, Inc

Biotechnology Research · 30 employees · Founded 2013 · Framingham, Massachusetts, United States

Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candidate, ALZ-801, is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain. ALZ-801 is an easy-to-take tablet that builds on the safety and efficacy profile of its active compound tramiprosate, which has been evaluated in clinical trials involving over Alzheimer’s patients. Our clinical expertise and technology platform are focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients.

alzheon.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Alzheon, Inc Preserving Future Memories

Find verified contacts for anyone on LinkedIn